Nagano Tatsuya

ナガノタツヤ | Nagano Tatsuya

Affiliation and department：
Job title： Assistant Professor

Research field (1)： Respiratory medicine

Research theme for competitive and other funds (6)：

2018 - 2021 超微小粒子PM0.1の呼吸器疾患へ与える影響の解析
2017 - 2020 肺腺がんの微小乳頭状構造のオルガノイド培養システムの確立
2017 - 2020 気管支サーモプラスティの効果予測因子の探索的研究
2016 - 2019 プロテオーム解析によるレタス誘発性喘息の原因抗原の同定
2014 - 2017 ホスホリパーゼCεを介した急性肺障害の新規治療法の開発

Show all

Papers (14)：

Katsurada M, Nagano Tatsuya, Tachihara Motoko, Kiriu T, Furukawa K, Koyama K, Otoshi T, Sekiya R, Hazama D, Tamura D, et al. Baseline Tumor Size as a Predictive and Prognostic Factor of Immune Checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer. Anticancer Res. 2019. 39. 2. 815-825
Katsurada Naoko, Tachihara Motoko, Jimbo Naoe, Koyama K, Nakata K, Nagano Tatsuya, Yamamoto Masatsugu, Otera Hiroshi, Kobayashi Kazuyuki, Nishimura Yoshihiro. Successful Treatment of ROS1-rearranged Lung Cancer Complicated by Hypertrophic Pulmonary Osteoarthropathy with Crizotinib Therapy: A Case Report. Intern Med. 2019
Kiriu T, Yamamoto Masatsugu, Nagano Tatsuya, Koyama K, Katsurada M, Tamura D, Nakata K, Tachihara Motoko, Kobayashi Kazuyuki, Nishimura Yoshihiro. Prognostic Value of Red Blood Cell Distribution Width in Non-small Cell Lung Cancer Treated With Anti-programmed Cell Death-1 Antibody. In Vivo. 2019. 33. 1. 213-220
UMEZAWA KANOKO, NAGANO TATSUYA, KOBAYASHI KAZUYUKI, DOKUNI RYOTA, KATSURADA MASAHIRO, YAMAMOTO MASATSUGU, YOSHIKAWA YOKO, KATAOKA TOHRU, NISHIMURA YOSHIHIRO. Phospholipase Cε plays a crucial role in neutrophilic inflammation accompanying acute lung injury through augmentation of CXC chemokine production from alveolar epithelial cells. Respiratory Research. 2019. 20. 9. 1-12
Umezawa K, Nagano Tatsuya, Kobayashi Kazuyuki, Dokuni R, Katsurada M, Yamamoto Masatsugu, Yoshikawa Yoko, Kataoka T, Nishimura Yoshihiro. Phospholipase Cε plays a crucial role in neutrophilic inflammation accompanying acute lung injury through augmentation of CXC chemokine production from alveolar epithelial cells. Respir Res. 2019. 20. 1. 9

ｍore...

MISC (3)：

Nagano Tatsuya, Tachihara Motoko, Nishimura Yoshihiro. Molecular Mechanisms and Targeted Therapies Including Immunotherapy for Non-Small Cell Lung Cancer. Curr Cancer Drug Targets. 2018
Nagano Tatsuya, Tachihara Motoko, Nishimura Yoshihiro. Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment Strategy. Cells. 2018. 7. 11
Nagano Tatsuya, TachiharaM, NishimuraY. Does ipilimumab show an increased clinical benefit when combined in sequence with chemotherapy?. Transl Cancer Res. 2018. 7. Suppl 1. S6-S9

Lectures and oral presentations (37)：

免疫チェックポイント阻害薬で治療したPD-L1陽性肺癌に対する好中球リンパ球比の検討
(第58回日本肺癌学会学術集会 2018)
免疫チェックポイント阻害剤投与例における赤血球容積粒度分布幅の有用性
(第59回日本肺癌学会学術集会 2018)
農作業関連喘息の疫学調査とプロテオーム解析による原因抗原の同定
(第27回Pneumo Forum 2018)
間質性陰影合併肺癌における抗PD-1抗体による間質性陰影増悪のリスク因子の検討
(第61回日本肺癌学会学術集会 2018)
S1P/S1PR3 pathway has the role in eosinophilic airway inflammation via release of CCL20 from bronchial epithelial cells
(Asian Pacific Society of Respirology 2018 2018)

ｍore...

Education (1)：

- 2011 Kobe University

Professional career (1)：

博士(医学) (神戸大学)

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page